Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03331458 · ClinicalTrials.gov registry record · NA

Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility Study

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT03331458 is a NA study that has completed, run by Duke University. The registered enrollment target is 13 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03331458, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

Recent research has indicated that physical activities incorporating moderate-intensity exercise can be safely performed during treatment and substantially reduces treatment-related side effects, such as fatigue, sleep disturbances, cognitive impairment, and nausea. However, little is known about physical activity levels prior to treatment and whether providing an exercise intervention pre-treatment may improve functional capacity during treatment. The purpose of this study is to 1. Measure physical activity levels and functional capacity in men newly diagnosed with prostate cancer prior to treatment and 2. Explore whether a 2-week physical activity intervention is feasible during the pre-treatment timeframe: 1. Examine intervention safety and tolerance by self-report 2. Examine changes in functional capacity by 6-minute walk test 3. Examine changes in symptom experience by self-report

Interventions

  • BEHAVIORAL exrecise intervention

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2018-04-17
Est. Completion 2019-03-21
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03331458

The ClinicalTrials.gov registry entry for NCT03331458 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which exrecise intervention is the first listed.

NCT03331458 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03331458 about?

NCT03331458 is a clinical study titled "Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility Study". Recent research has indicated that physical activities incorporating moderate-intensity exercise can be safely performed during treatment and substantially reduces treatment-related side effects, such as fatigue, sleep disturbances, cognitive impairment, and nausea. However, little is known about ph...

What is the current status of trial NCT03331458?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2018-04-17. Estimated completion is 2019-03-21.

What interventions are being tested in trial NCT03331458?

The interventions under investigation include: exrecise intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03331458?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.